Global CDMO operating development and manufacturing across 10 countries
Recipharm is a contract development and manufacturing organization (CDMO) operating development and manufacturing facilities across France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK, and the US. The tech stack is heavily weighted toward manufacturing operations (HPLC, qPCR, SDS-PAGE, SCADA, CMMS) and enterprise systems (SAP R/3, Veeva, LIMS), with active projects focused on aseptic process optimization, equipment implementation, and SAP-based planning — indicating operational maturity paired with ongoing system standardization across geographies. Hiring is manufacturing-heavy (40% of roles), concentrated at entry and junior levels, reflecting either scaling or high turnover in shop-floor operations.
Recipharm provides full-service contract manufacturing and development for pharmaceutical companies, handling products from early development through commercial production. The company operates with 5,200 employees across ten countries and offers services spanning drug substance and drug product manufacturing, formulation development, analytical services, biologics, and advanced therapies. Their core challenges revolve around GMP compliance, aseptic process validation, equipment maintenance, and sterility assurance—typical of regulated manufacturing at scale. Active initiatives include plant expansion, cleanroom optimization, and migration to SAP-based planning systems.
Recipharm operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK, and the US, with ongoing expansion planned.
Core stack includes SAP R/3 for ERP, LIMS for lab data, Veeva for compliance, SCADA/CMMS for equipment control and maintenance, and Power BI for dashboards, alongside HPLC and qPCR for analytical work.
Other companies in the same industry, closest in size